A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

Mann, H. B., & Whitney, D. R. (1947) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177730491 · Cited by 14,320 · see citing works

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

Fisher, R. A. (1922) · Journal Of The Royal Statistical Society · doi:10.2307/2340521 · Cited by 2,975 · see citing works

Influence of tumour micro-environment heterogeneity on therapeutic response

Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694 · see citing works

Drug Resistance and the Solid Tumor Microenvironment

Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · see citing works

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771 · see citing works

Design and Analysis of Experiments

Gupta, A. K., & Kabe, D. G. (2013) · WORLD SCIENTIFIC eBooks · doi:10.1142/8889 · Cited by 1,250 · see citing works

Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries

Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A. M., Yasgar, A., Zheng, W., & Austin, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604348103 · Cited by 794 · see citing works

The role of tumour-stromal interactions in modifying drug response: challenges and opportunities

McMillin, D. W., Negri, J. M., & Mitsiades, C. S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3870 · Cited by 474 · see citing works

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

Griner, L. A. M., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C. G., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 381 · see citing works

Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism

Liao, J., Qian, F., Tchabo, N. E., Mhawech-Fauceglia, P. Y., Beck, A. F., Zikun, Q., Wang, X., Huss, W. J., Lele, S., Morrison, C. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084941 · Cited by 365 · see citing works

Psammaplins from the Sponge Pseudoceratina purpurea: Inhibition of Both Histone Deacetylase and DNA Methyltransferase

Piña, I. C., Gautschi, J. T., Wang, G.-Y.-S., Sanders, M. L., Schmitz, F. J., France, D. S., Cornell-Kennon, S., Sambucetti, L. C., Remiszewski, S., Perez, L. B., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo034248t · Cited by 314 · see citing works

Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion

Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303 · see citing works

Targeting Tumor Angiogenesis with Histone Deacetylase Inhibitors: the Hydroxamic Acid Derivative LBH589

Qian, D. Z., Kato, Y., Shabbeer, S., Wei, Y., Verheul, H. M. W., Salumbides, B. C., Sanni, T. B., Atadja, P. W., & Пили, Р. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1132 · Cited by 267 · see citing works

Use of a Novel 3D Culture Model to Elucidate the Role of Mesothelial Cells, Fibroblasts and Extra-cellular Matrices on Adhesion and Invasion of Ovarian Cancer Cells to the Omentum

Kenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243 · see citing works

A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Modesitt, S. C., Sill, M. W., Hoffman, J. S., & Bender, D. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.009 · Cited by 225 · see citing works

Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133 + Ovarian Cancer Stem‐Like Cells via NF‐κB‐Mediated MMP‐9 Upregulation

Long, H., Xie, R., Xiang, T., Zhao, Z., Lin, S., Liang, Z., Chen, Z., & Zhu, B. (2012) · Stem Cells · doi:10.1002/stem.1194 · Cited by 204 · see citing works

Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy

Kenny, H. A., Lal‐Nag, M., White, E. A., Shen, M., Chiang, C.-Y., Mitra, A. K., Zhang, Y., Curtis, M., Schryver, E. M., Bettis, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7220 · Cited by 172 · see citing works

Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance

Scully, R. E., & Richardson, G. S. (1961) · Cancer · doi:10.1002/1097-0142(199007/08)14:4 · Cited by 128 · see citing works

A Grid Algorithm for High Throughput Fitting of Dose-Response Curve Data

Wang, Y., Jadhav, A., Southal, N., Huang, R., & Nguyễn, Ð.-T. (2010) · Current Chemical Genomics · doi:10.2174/1875397301004010057 · Cited by 123 · see citing works

α2β1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis

Shield, K., Riley, C. B., Quinn, M. A., Rice, G. E., Ackland, M. L., & Ahmed, N. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-11 · Cited by 119 · see citing works

Human ovarian carcinoma cells: Histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis

Takai, N., Kawamata, N., Gui, D., SAID, J. W., Miyakawa, I., & Koeffler, H. P. (2004) · Cancer · doi:10.1002/cncr.20709 · Cited by 118 · see citing works

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro

Green, S. K., Francia, G., Isidoro, C., & Kerbel, R. S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.149.3.2 · Cited by 107 · see citing works

High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations

Mott, B. T., Eastman, R. T., Guha, R., Sherlach, K. S., Siriwardana, A., Shinn, P., McKnight, C. G., Michael, S., Lacerda‐Queiroz, N., Patel, P., et al. (2015) · Scientific Reports · doi:10.1038/srep13891 · Cited by 104 · see citing works

Bone Marrow Stroma–Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor

Manshouri, T., Estrov, Z. E., Quintás‐Cardama, A., Burger, J. A., Zhang, Y., Livun, A., Knez, L., Harris, D., Creighton, C. J., Kantarjian, H. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4002 · Cited by 100 · see citing works

Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: Implications for therapy

Khabele, D., Son, D., Parl, A. K., Goldberg, G. L., Augenlicht, L. H., Mariadason, J. M., & Rice, V. M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.4007 · Cited by 99 · see citing works

The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance

Shain, K. H., Landowski, T. H., & Dalton, W. S. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00008 · Cited by 99 · see citing works

Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2–dependent adult T-cell leukemia

Zhang, M., Griner, L. A. M., Ju, W., Duveau, D. Y., Guha, R., Petrus, M. N., Wen, B., Maeda, M., Shinn, P., Ferrer, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516208112 · Cited by 92 · see citing works

Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells

Terao, Y., Nishida, J.-I., Horiuchi, S., Rong, F., Ueoka, Y., Matsuda, T., Kato, H., Furugen, Y., Yoshida, K., Kato, K., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1448 · Cited by 89 · see citing works

Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation

Fang, Z., Zhang, T., Dizeyi, N., Chen, S., Wang, H., Swanson, K. D., Cai, C., Balk, S. P., & Yuan, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323303 · Cited by 69 · see citing works

Histone deacetylase inhibitors enhance paclitaxel-induced cell death in ovarian cancer cell lines independent of p53 status.

Chobanian, N. H., Greenberg, V. L., Gass, J. M., DeSimone, C. P., van Nagell, J. R., & Zimmer, S. G. (2004) · PubMed · Cited by 52 · see citing works

Advanced ovarian cancer: what should be the standard of care?

Goff, B. A. (2013) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2013.24.1.83 · Cited by 48 · see citing works

Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells

Sonnemann, J., Hüls, I., Sigler, M., Palani, C. D., Hong, L. T. T., Völker, U., Kroemer, H. K., & Beck, J. F. (2008) · Oncology Reports · doi:10.3892/or.20.1.219 · Cited by 31 · see citing works

Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer

Shao, Z. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.677 · Cited by 22 · see citing works

Revisiting the Role of Antiandrogen Strategies in Ovarian Cancer

Papadatos-Pastos, D., Dedes, K. J., Bono, J. S. D., & Kaye, S. B. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0164 · Cited by 22 · see citing works

Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia

Zhang, M., Griner, L. A. M., Ju, W., Duveau, D. Y., Guha, R., Petrus, M. N., Wen, B., Maeda, M., Shinn, P., Ferrer, M., et al. (2015) · Retrovirology · doi:10.1186/1742-4690-12-s1-o42 · Cited by 10 · see citing works

Could 3D models of cancer enhance drug screening?

Brancato, V., Oliveira, J. M., Correlo, V. M., Reis, R. L., & Kundu, S. C. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119744 · Cited by 283 · see citing works

3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro

Brancato, V., Gioiella, F., Imparato, G., Guarnieri, D., Urciuolo, F., & Netti, P. A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.055 · Cited by 86 · see citing works

Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine

Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66 · see citing works

A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models

Parrish, J., Lim, K. S., Baer, K., Hooper, G. J., & Woodfield, T. B. F. (2018) · Lab on a Chip · doi:10.1039/c8lc00485d · Cited by 57 · see citing works

An omentum-inspired 3d peg hydrogel for identifying ecm-drivers of drug resistant ovarian cancer

Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5091713 · Cited by 51 · see citing works

The Endometriotic Tumor Microenvironment in Ovarian Cancer

Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51 · see citing works

Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment

Watters, K. M., Bajwa, P., & Kenny, H. A. (2018) · Cancers · doi:10.3390/cancers10080265 · Cited by 49 · see citing works

A Dynamic Culture Method to Produce Ovarian Cancer Spheroids under Physiologically-Relevant Shear Stress

Masiello, T. J., Dhall, A., Hemachandra, L. P. M. P., Tokranova, N. A., Melendez, J. A., & Castracane, J. (2018) · Cells · doi:10.3390/cells7120277 · Cited by 49 · see citing works

Three dimensional engineered models to study hypoxia biology in breast cancer

Aggarwal, V., Miranda, O., Johnston, P. A., & Sant, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.030 · Cited by 40 · see citing works

Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis

McGuire, S., Kara, B., Hart, P. C., MONTAG, A. G., Wroblewski, K., Fazal, S., Huang, X., Lengyel, E. R., & Kenny, H. A. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.01.020 · Cited by 37 · see citing works

Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis

Kenny, H. A., Lal‐Nag, M., Shen, M., Kara, B., Nahotko, D. A., Wroblewski, K., Fazal, S., Chen, S., Chiang, C.-Y., Chen, Y., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0052 · Cited by 29 · see citing works

Trends in Bone Metastasis Modeling

Laranga, R., Duchi, S., Ibrahim, T., Guerrieri, A. N., Donati, D. M., & Lucarelli, E. (2020) · Cancers · doi:10.3390/cancers12082315 · Cited by 29 · see citing works

Recapitulating Tumorigenesis in vitro: Opportunities and Challenges of 3D Bioprinting

Kronemberger, G. S., Miranda, G. A. S. C., Tavares, R. S. N., Montenegro, B. M., Kopke, Ú. D. A., & Baptista, L. S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.682498 · Cited by 27 · see citing works

From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity

Gambara, G., Gaebler, M., Keilholz, U., Regenbrecht, C. R. A., & Silvestri, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00077 · Cited by 22 · see citing works

In Vitro Models of Ovarian Cancer: Bridging the Gap between Pathophysiology and Mechanistic Models

Lopez, E., Kamboj, S., Chen, C., Wang, Z., Kellouche, S., Leroy‐Dudal, J., Carreiras, F., Lambert, A., & Aimé, C. (2023) · Biomolecules · doi:10.3390/biom13010103 · Cited by 21 · see citing works

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery

Eglen, R. M., & Klein, J.-L. D. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217702448 · Cited by 19 · see citing works

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research

Clark, J. A., Fotopoulou, C., Cunnea, P., & Krell, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837233 · Cited by 13 · see citing works

Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments

Battistini, C., & Cavallaro, U. (2023) · Cancers · doi:10.3390/cancers15020368 · Cited by 12 · see citing works

Time-lapse imaging of HeLa spheroids in soft agar culture provides virtual inner proliferative activity

Minamikawa‐Tachino, R., Ogura, K., Ito, A., & Nagayama, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231774 · Cited by 12 · see citing works

Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery

Silvestri, A., Vicente, F., Vicent, M. J., Stechmann, B., & Fecke, W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.024 · Cited by 11 · see citing works

Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth

Kenny, H. A., Ip, C. K. M., Kelliher, L., Samantaray, T., Kordylewicz, K., Hoffmann, R., Rauch, S., Malacrida, B., Skingsley, S. L. P., Balkwill, F. R., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0863 · Cited by 8 · see citing works

Identification of the polyether ionophore lenoremycin through a new screening strategy for targeting cancer stem cells

Ikeda, H., Kawami, M., Imoto, M., & Kakeya, H. (2022) · The Journal of Antibiotics · doi:10.1038/s41429-022-00571-1 · Cited by 7 · see citing works

Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity

Hart, P. C., Bajwa, P., & Kenny, H. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73359-9_5 · Cited by 3 · see citing works

An Omentum-inspired 3D PEG Hydrogel for Identifying ECM-drivers of Drug Resistant Ovarian CancerPreprint

Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/560482 · Cited by 4 · see citing works

Study of cell and drug interactions based on dual-mode detection using SPR and fluorescence imaging

Zhang, L., Liu, R., Liu, L., Xing, X., Cai, H., Fu, Y., Sun, J., Ruan, W., Chen, J., Qiu, X., et al. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124170 · Cited by 3 · see citing works

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Das, S., Illangeswaran, R. S. S., Ijee, S., Kumar, S., Velayudhan, S. R., & Balasubramanian, P. (2022) · Journal of Visualized Experiments · doi:10.3791/63383 · Cited by 2 · see citing works

The Development of a Three-Dimensional Platform for Patient-Derived Ovarian Cancer Tissue Models: A Systematic Literature Review

Sevinyan, L., Gupta, P., Velliou, E. G., & Madhuri, T. K. (2022) · Cancers · doi:10.3390/cancers14225628 · Cited by 2 · see citing works

Construction of Multicellular Tumor-on-a-Chip Models for Ovarian Cancer Research

Ye, J., Lin, H., Zhang, Z., Xu, S., Yang, F. L., ZhuanSun, X.-M., Ji, F., Zhang, Y. F., Zhu, Y., Zhang, J., et al. (2025) · Engineering · doi:10.1016/j.eng.2025.08.028 · Cited by 1 · see citing works

Engineering immune-competent niches: strategies, applications, and translational hurdles in ovarian cancer organoid models

Chen, Y., Xu, N. L. J., Dong, M., Liu, W., Liu, Z., Sun, G., & Jia, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1773734 · Cited by 2 · see citing works

Ovarian cancer stem cell biology and chemoresistance

Waters, J. A., & House, C. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819840-7.00009-1 · Cited by 1 · see citing works

The development and application of a ChIP and MeDIP assay to determine a link between epigenetics and metabolism in ovarian cancer progression

TSE, C. (2022) · doi:10.23889/suthesis.60060

Advances in Research and Applications of Cardiac Organoids

Ding, F. (2023) · MEDS Clinical Medicine · doi:10.23977/medsc.2023.040612

A Novel ex-vivo platform for personalized treatment in metastatic ovarian cancerPreprint

Valdivia, A., Adefolaju, A., Thang, M., Cuaboy, L. A., John, C. S., Mann, B., Satterlee, A., Bae-Jump, V. L., & Hingtgen, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.14.585117

Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy

Kenny, H. A., Lal‐Nag, M., White, E. A., Shen, M., Chiang, C.-Y., Mitra, A. K., Zhang, Y., Curtis, M., Schryver, E. M., Bettis, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms7220 · Cited by 172 · see citing works

Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis

Kenny, H. A., Lal‐Nag, M., Shen, M., Kara, B., Nahotko, D. A., Wroblewski, K., Fazal, S., Chen, S., Chiang, C.-Y., Chen, Y., et al. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0052 · Cited by 29 · see citing works

Collagen-based three-dimensional culture microenvironment promotes epithelial to mesenchymal transition and drug resistance of human ovarian cancer <i>in vitro</i>

Liu, M., Zhang, X., Long, C., Xu, H., Cheng, X., Chang, J., Zhang, C., Zhang, C., & Wang, X. (2018) · RSC Advances · doi:10.1039/c7ra13742g · Cited by 48 · see citing works

Targeting the tumour microenvironment in ovarian cancer

Hansen, J. M., Coleman, R. L., & Sood, A. K. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.016 · Cited by 122 · see citing works

Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays

Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020) · Biotechnology Progress · doi:10.1002/btpr.3034 · Cited by 33 · see citing works